Cherry Creek Investment Advisors, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Cherry Creek Investment Advisors, Inc.
- $196 Million
- Q4 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 62,127 shares of RXRX stock, worth $449,799. This represents 0.21% of its overall portfolio holdings.
Number of Shares
62,127
Previous 57,340
8.35%
Holding current value
$449,799
Previous $377,000
11.14%
% of portfolio
0.21%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
299Shares Held
241MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$237 Million2.05% of portfolio
-
Baillie Gifford & CO24.9MShares$180 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$125 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$111 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.31B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...